IP Library Granted Patent US 11,278,047
Granted Patent B2
US 11,278,047 · App. 16/321,559 · Granted Mar 22, 2022

Lipid composition for use in infants and young children for promoting gut comfort and optimal fat and calcium absorption

Inventors: Frederic Destaillats (Servion, CH); Valerie Petit (Thonon-les-Bains, FR)
Assignee: Societe des Produits Nestle S.A.
A23L33/40A23L33/12A61K31/20A61K31/702A23V2002/00A23V2250/1886A23V2250/206A23V2250/502A23V2250/54246A23V2250/54252A23V2250/55A23V2250/612Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,047
App. No.
16/321,559
Granted
Mar 22, 2022
Kind
B2
Abstract

The present invention relates to a nutritional composition, for infants and young children (about 12 to 36 months) in which the sum of the triacylglycerols (TAG) sn-1(3) palmitic acid (PA), myristic acid (MA) and stearic acid (SA) constitutes less than 13.0% of the TAG. The composition promotes absorption of fatty acids and calcium in the gut, improves gut comfort, decreases abdominal pain associated with hard stool formation, promotes regular bowel movements and reduces the incidence and severity of constipation in infants and young children (up to the age of about three years old). The composition also promotes bone mineralization, increasing bone strength and bone mineral density.

Claims (16)

1. A method for at least one of (i) reducing digestive discomfort, (ii) reducing abdominal pain, (iii) reducing an incidence and/or severity of colic, or (iv) reducing an incidence and/or severity of constipation, in an infant or young child in need thereof, the method comprising:

administering to the infant or young child a composition comprising protein, carbohydrates and lipids,

the lipids comprising fatty acid (FA) triacylglycerols (TAG), the fatty acid TAG comprising stearic, palmitic and myristic esters,

wherein the sum of the amount of the stearic, palmitic and myristic esters at the sn-1(3) position of the TAG is less than 13.0% (w/w) of TAG, and the myristic acid represents up to 3.6% of the total FA, the palmitic acid represents up to 11.1% of the total FA, and the stearic acid represents up to 4.6% of the total FA (w/w),

the lipids comprise a mixture of oils, the mixture of oils is selected from the group consisting of:

a) 17.3 to 21.1% of rapeseed oil, 11.5 to 14.1% of sunflower oil, 41.9 to 51.3% of high oleic sunflower oil, and 18.0 to 22.0% of coconut oil;

b) 16.9 to 20.7% of rapeseed oil, 11.3 to 13.9% of sunflower oil, 42.1 to 51.5% of high oleic sunflower oil, and 17.5 to 21.5% of coconut oil; and

c) 23.9 to 29.3% of milk fat, 15.8 to 19.4% of rapeseed oil, 8.2 to 10.0% of sunflower oil, and 39.2 to 48.0% of high oleic sunflower oil.

2. The method of claim 1 wherein the composition is administered in an amount effective for reducing stool hardness in the infant or young child.

3. The method of claim 1 wherein the composition is administered in an amount effective for increasing bone mineralization, increasing bone strength, and/or increasing bone mineral density in the infant or young child.

4. The method of claim 1 , wherein the carbohydrates comprise 99% to 100% of lactose.

5. The method of claim 1 , wherein the amount of the protein in the composition is up to 2.1 g protein/100 kcal of composition.

6. The method of claim 1 , wherein the protein is a mixture of whey protein and casein having a ratio of the whey protein to the casein between 50:50 and 80:20.

7. The method of claim 1 , wherein the protein is partially hydrolyzed.

8. The method of claim 1 , wherein the composition further comprises at least one additional component selected from the group consisting of a prebiotic and a probiotic.

9. The method of claim 1 , wherein the lipids are selected from the group consisting of docosahexaenoic acid (DHA), arachidonic acid (ARA), eicosapentaenoic acid (EPA and mixtures thereof.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2022
From: DESTAILLATS, FREDERIC; PETIT, VALERIE
To: NESTEC S.A.
Reel/Frame 058997/0549 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Priority Claims (1)
EP 16183006 · Aug 5, 2016 · regional
Continuity (1)
Related Publication 20190166898A1 · Jun 6, 2019